WSTAM
MJN

Wilbanks Smith & Thomas Asset Management’s Mead Johnson Nutrition Company MJN Stock Holding History

Wilbanks Smith & Thomas Asset Management’s Portfolio MJN Stock Details MJN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-2,420
Closed -$216K – 360
2017
Q1 		$216K Buy
+2,420
New +$199K 0.02% 291

Other funds holding MJN

PAMU
Pictet Asset Management (UK) London, United Kingdom $91.8B AUM 47.77% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
FNBOO
First National Bank of Omaha Omaha, Nebraska $3.55B AUM 27.24% 1-Year Est. Return
LFAS
Level Four Advisory Services Dallas, Texas $3.05B AUM 23.96% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
CPIG
Chicago Partners Investment Group Chicago, Illinois $5B AUM 26.84% 1-Year Est. Return
WEC
Winslow Evans & Crocker Boston, Massachusetts $528M AUM 30.99% 1-Year Est. Return

Wilbanks Smith & Thomas Asset Management's MJN Position: Q2 2017 in Review

Wilbanks Smith & Thomas Asset Management sold out of Mead Johnson Nutrition Company (MJN) in Q2 2017, closing a stake of 2,420 shares — an estimated $216K sold.

Wilbanks Smith & Thomas Asset Management first reported a position in MJN in Q1 2017 and held it in 1 quarter. The position peaked at $216K in Q1 2017. 7 funds tracked by Wall St. Rank hold MJN as of Q2 2017.

  • Wilbanks Smith & Thomas Asset Management reported no remaining Mead Johnson Nutrition Company position as of Q2 2017 after selling out during the quarter.
  • Wilbanks Smith & Thomas Asset Management sold 2,420 Mead Johnson Nutrition Company shares in Q2 2017, an estimated $216K.
  • Wilbanks Smith & Thomas Asset Management first reported a position in Mead Johnson Nutrition Company in Q1 2017 and held it in 1 quarter.
  • Wilbanks Smith & Thomas Asset Management's Mead Johnson Nutrition Company position peaked at $216K in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Mead Johnson Nutrition Company as of Q2 2017.

Based on Wilbanks Smith & Thomas Asset Management's 13F filing for Q2 2017, filed 15 Aug 2017.